NOS2 and neoplasm: In tumor, the MDSCs metabolic reprogramming enhances the immunosuppressive activity of Arg1 and iNOS, which will lead to apoptosis of effector T cells and suppression of cell proliferation, and promote tumor proliferation and metastasis (133, 134).